ArticleFrontiers in plant science2019
Article in Frontiers in plant science, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed, 98 citations in OpenAlex.
- Grapevine exarcerbates the virulence ofFrontiers in plant science · 2026Article
- Whole-Genome Analysis of PGP EndophyticInternational journal of molecular sciences · 2025Article
- Native Bacteria Are Effective Biocontrol Agents at a Wide Range of Temperatures ofPlants (Basel, Switzerland) · 2025Article
- Diversity and functional features of the root-associated bacteriome are dependent on grapevine susceptibility to Plasmopara viticola.Environmental microbiome · 2025Article
- A review on fungal endophytes of the family Fabaceae, their metabolic diversity and biological applications.Heliyon · 2025Review
- Assessment of the potential of novel Californian grapevineFrontiers in plant science · 2025Article
- Article
- Microbial Biological Control of Fungi Associated with Grapevine Trunk Diseases: A Review of Strain Diversity, Modes of Action, and Advantages and Limits of Current Strategies.Journal of fungi (Basel, Switzerland) · 2023Review
- Biocontrol Potential of an EndophyticPlants (Basel, Switzerland) · 2023Article
- The Combination of Both Heat and Water Stresses May Worsen Botryosphaeria Dieback Symptoms in Grapevine.Plants (Basel, Switzerland) · 2023Article
- Holistic understanding of the response of grapevines to foliar application of seaweed extracts.Frontiers in plant science · 2023Article
- Sodium arsenite-induced changes in the wood of esca-diseased grapevine at cytological and metabolomic levels.Frontiers in plant science · 2023Article
- Evaluation of the Antifungal Activity of Endophytic and Rhizospheric Bacteria against Grapevine Trunk Pathogens.Microorganisms · 2022Article
- Diversity ofJournal of fungi (Basel, Switzerland) · 2022Article
- Assessment of a New Copper-Based Formulation to Control Esca Disease in Field and Study of Its Impact on the Vine Microbiome, Vine Physiology and Enological Parameters of the Juice.Journal of fungi (Basel, Switzerland) · 2022Article
- D-Tagatose-Based Product Triggers Sweet Immunity and Resistance of Grapevine to Downy Mildew, but Not to Gray Mold Disease.Plants (Basel, Switzerland) · 2022Article
- The road to molecular identification and detection of fungal grapevine trunk diseases.Frontiers in plant science · 2022Review
- Modification of Early Response ofFrontiers in microbiology · 2022Article
- Insights of theJournal of fungi (Basel, Switzerland) · 2021Article
- Production of Phytotoxic Metabolites by Botryosphaeriaceae in Naturally Infected and Artificially Inoculated Grapevines.Plants (Basel, Switzerland) · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 4 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Plant pathogens have evolved various strategies to enter hosts and cause diseases. Particularly
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.